STAAR Surgical | STAA - Selling And Administration Expenses


STAAR Surgical reported $43.22M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Bausch Health Companies USD 834M 67M Sep/2026
Boston Scientific USD 1.68B 120M Sep/2026
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 401.3M 274.9M Jun/2026
J&J USD 6.25B 168M Sep/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Novartis USD 3.08B 163M Sep/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 43.22M 1.92M Sep/2026
Utah Medical Products USD 2.56M 48K Mar/2026